未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Disitamab vedotin plus toripalimab in patients with locally advanced or metastatic urothelial carcinoma (RC48-C014): a phase Ib/II dose-escalation and dose-expansion study Disitamab vedotin联合toripalimab治疗局部晚期或转移性尿路上皮癌 (RC48-C014): Ib/II期剂量递增和剂量扩展研究 Zhou, L.; Yang, K. W.; Zhang, S.; Yan, X. Q.; Li, S. M.; Xu, H. Y.; Li, J.; Liu, Y. Q.; Tang, B. X.; Chi, Z. H.; Si, L.; Cui, C. L.; Guo, H. Q.; He, Z. S.; Guo, J.; Sheng, X. 分享 收藏
Synergistic effects of pH and nano-calcium carbonate on sodium alginate gels and their application for encapsulation, protection, delivery and yoghurt of probiotics Wang, Kaili; Zhao, Xu; Chi, Houyu; Hou, Zhanqun; Li, Chun; Ma, Yiming; Guo, Jianming; Li, Aili; Zhang, Guofang 分享 收藏
分享 收藏
Efficacy and safety of cadonilimab plus lenvatinib in previously immunotherapy treated advanced/metastatic clear cell renal cell carcinoma (ccRCC): A multicenter, single-arm, phase II trial 卡度尼利单抗联合仑伐替尼在既往接受过免疫治疗的晚期/转移性透明细胞肾细胞癌(ccRCC)中的疗效与安全性:一项多中心、单臂、II期临床试验 Huang, J.; Zhao, J.; Hu, X.; Kong, W.; Chen, Q.; Zhang, J.; Chen, Y.; Guo, J.; Xu, D.; Xue, W. 分享 收藏
RETRACTION: KDM4 orchestrates epigenomic remodeling of senescent cells and potentiates the senescence-associated secretory phenotype (Retraction of Vol 1, Pg 454, 2021) 撤稿:KDM4 协调衰老细胞的表观基因组重塑并增强衰老相关分泌表型(撤稿自 Vol 1, Pg 454, 2021) Zhang, Boyi; Long, Qilai; Wu, Shanshan; Xu, Qixia; Song, Shuling; Han, Liu; Qian, Min; Ren, Xiaohui; Liu, Hanxin; Jiang, Jing; Guo, Jianming; Zhang, Xiaoling; Chang, Xing; Fu, Qiang; Lam, Eric W-F; Campisi, Judith; Kirkland, James L.; Sun, Yu 分享 收藏
Inhibitory effects of platinum nanoparticles coated with polyethylene glycol and conjugated with Rutin on the MCF-7 breast cancer cell line 聚乙二醇包被的铂纳米粒子与芦丁偶联对MCF-7乳腺癌细胞的抑制作用 Li, Yue; Guo, Jianming; Gong, Xue; Zhang, Huanyu; Ma, Keru; Sui, Yuan; Chen, Baihui; Du, Yubo; Chen, Tianyu; Yang, Dongxu; Li, Dalin 分享 收藏
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III study Yan, X. Q.; Yey, M. J.; Zou, Q.; Chen, P.; He, Z. S.; Wu, B.; He, D. L.; He, C. H.; Xue, X. Y.; Ji, Z. G.; Chen, H.; Zhang, S.; Liu, Y. P.; Zhang, X. D.; Fu, C.; Xu, D. F.; Qiu, M. X.; Lv, J. J.; Huang, J.; Ren, X. B.; Cheng, Y.; Qin, W. J.; Zhang, X.; Zhou, F. J.; Ma, L. L.; Guo, J. M.; Ding, D. G.; Wei, S. Z.; He, Y.; Guo, H. Q.; Shi, B. K.; Liu, L.; Liu, F.; Hu, Z. Q.; Jin, X. M.; Yang, L.; Zhu, S. X.; Liu, J. H.; Huang, Y. H.; Xu, T.; Liu, B.; Sun, T.; Wang, Z. J.; Jiang, H. W.; Yu, D. X.; Zhou, A. P.; Jiang, J.; Luan, G. D.; Jin, C. L.; Xu, J.; Hu, J. X.; Huang, Y. R.; Guo, J.; Zhai, W.; Sheng, X. N. 分享 收藏
Heterogeneous MXene Hybrid-Oriented Exosome Isolation and Metabolic Profiling for Early Screening, Subtyping and Follow-up Evaluation of Bladder Cancer Chen, Haolin; Qi, Yu; Yang, Chenyu; Tai, Qunfei; Zhang, Man; Shen, Xi-Zhong; Deng, Chunhui; Guo, Jianming; Jiang, Shuai; Sun, Nianrong 分享 收藏
A novel in vitro prognostic model of bladder cancer based on urine-derived living tumor cells Wang, Jiaqi; Zhu, Jiying; Hu, Junchi; Wang, Ziruoyu; Wang, Xiaobo; Pan, Jianbo; Chu, Yiwei; Li, Zengxia; Jiang, Wei; Liang, Chunmin; Hou, Jun; Guo, Jianming; Dang, Yongjun; Jiang, Shuai 分享 收藏
Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ Yao, Zhenmei; Xu, Ning; Shang, Guoguo; Wang, Haixing; Tao, Hui; Wang, Yunzhi; Qin, Zhaoyu; Tan, Subei; Feng, Jinwen; Zhu, Jiajun; Ma, Fahan; Tian, Sha; Zhang, Qiao; Qu, Yuanyuan; Hou, Jun; Guo, Jianming; Zhao, Jianyuan; Hou, Yingyong; Ding, Chen 分享 收藏
分享 收藏
分享 收藏
分享 收藏
Prognostic value of tumour contour irregularity on surgical strategies for T1bN0M0 renal cell carcinoma: A multi-institutional study Xu, Peirong; Zhang, Sihong; Cheng, Jiangting; Cao, Bohong; Huang, Jiaqi; Li, Yaohui; Lin, Wenyao; Li, Huifeng; Chen, Weijie; Zhu, Yanjun; Jiang, Shuai; Hu, Xiaoyi; Wu, Jiawen; Wu, Zhenqi; Zhou, Jianjun; Guo, Jianming; Cheng, Jie; Wang, Hang 分享 收藏
分享 收藏